The First AI Designed Drugs Are in the Clinic: 200 Candidates, Zero Approvals, and the Race to the First FDA Win - June 4, 2026

The First AI Designed Drugs Are in the Clinic: 200 Candidates, Zero Approvals, and the Race to the First FDA Win - June 4, 2026 More than 200 AI discovered drug candidates are now in human trials, yet not one has been approved. We dig into Insilico Medicine's Rentosertib, Relay Therapeutics' Zovegalisib, Eli Lilly's 2.75 billion dollar Insilico deal, and the LillyPod supercomputer to ask whether 2026 through 2028 is the make or break window for the first FDA approval of an AI designed medici...